Skip to main content

Table 1 Patient Characteristics (Study A and B)

From: Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies

Characteristic Number
Age 63 (range 34-75)
ECOG PS 0* 3
ECOG PS 1 16
Males 12
Females 7
White 18
Hispanic 1
Prior surgery 6
Prior radiation 2
Prior chemotherapy regimens  
1 5
2 8
≥ 3 2
  1. * ECOG PS: Eastern Co-operative Oncology Group Performance Status